Perioperative or neo/adjuvant chemoimmunotherapy versus chemotherapy for resectable non-small cell lung cancer: a systematic review and network meta-analysis.

Syst Rev · 2025 · PMC11760710 · PMID 39856765

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

In recent years, immunotherapy has increasingly emerged as a significant trend in cancer treatment, and combined immunotherapy has progressed from late-stage treatments to the perioperative phase in lung cancer [ 2 ].

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.